BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 20038322)

  • 1. [OCT4 expression in hepatocellular carcinoma and its clinical significance].
    Huang PZ; Lu CL; Li BK; Hong J; Huang L; Wang L; Zhang Y; Yuan YF
    Chin J Cancer; 2010 Jan; 29(1):111-16. PubMed ID: 20038322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomy.
    Huang P; Qiu J; Li B; Hong J; Lu C; Wang L; Wang J; Hu Y; Jia W; Yuan Y
    Clin Biochem; 2011 Jun; 44(8-9):582-9. PubMed ID: 21376027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of combination of CD90 and OCT4 for hepatocellular carcinoma after curative resection.
    Zhao RC; Zhou J; Chen KF; Gong J; Liu J; He JY; Guan P; Li B; Qin Y
    Neoplasma; 2016; 63(2):288-98. PubMed ID: 26674131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of OCT4 is associated with low differentiation and tumor recurrence in human hepatocellular carcinoma.
    Dong Z; Zeng Q; Luo H; Zou J; Cao C; Liang J; Wu D; Liu L
    Pathol Res Pract; 2012 Sep; 208(9):527-33. PubMed ID: 22824146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of stemness factors Oct4 and Nanog predict liver resection.
    Yin X; Li YW; Zhang BH; Ren ZG; Qiu SJ; Yi Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2877-87. PubMed ID: 22461131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
    Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M
    World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma.
    Cheng SW; Tsai HW; Lin YJ; Cheng PN; Chang YC; Yen CJ; Huang HP; Chuang YP; Chang TT; Lee CT; Chao A; Chou CY; Chan SH; Chow NH; Ho CL
    PLoS One; 2013; 8(11):e80053. PubMed ID: 24244607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
    Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
    Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NADPH oxidase DUOX1 and DUOX2 but not NOX4 are independent predictors in hepatocellular carcinoma after hepatectomy.
    Lu CL; Qiu JL; Huang PZ; Zou RH; Hong J; Li BK; Chen GH; Yuan YF
    Tumour Biol; 2011 Dec; 32(6):1173-82. PubMed ID: 21915726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
    Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
    Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LIN28 expression and prognostic value in hepatocellular carcinoma patients who meet the Milan criteria and undergo hepatectomy.
    Qiu JL; Huang PZ; You JH; Zou RH; Wang L; Hong J; Li BK; Zhou K; Yuan YF
    Chin J Cancer; 2012 May; 31(5):223-32. PubMed ID: 22429493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression Pattern and Clinical Significance of Gab2 Protein in Hepatocellular Carcinoma.
    Hu X; He B; Zhou L; Xie H; Zheng S
    Clin Lab; 2016; 62(6):1087-92. PubMed ID: 27544933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low levels of glycoprotein 96 indicate a worse prognosis in early-stage hepatocellular carcinoma patients after hepatectomy.
    Ji F; Zhang Y; Zhu ZB; Guo Y; Shen SL; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
    Hum Pathol; 2019 Apr; 86():193-202. PubMed ID: 30529751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of long noncoding RNA linc00261 in hepatocellular carcinoma and its association with postoperative outcomes].
    Chen Z; Xiang L; Huang Y; Fang Y; Li X; Yang D
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1179-1186. PubMed ID: 30377132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of mucin 15 in hepatocellular carcinoma and its clinical implications].
    Liu Q; Tian Q; Zhang H; Zheng X; Yao Y; Liu Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Nov; 34(11):1611-5. PubMed ID: 25413059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of CXCR3 in hepatocellular carcinoma].
    Shi M; Guo RP; Zhang CQ; Zhong C; Lin XJ; Li JQ
    Ai Zheng; 2006 Oct; 25(10):1232-7. PubMed ID: 17059766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.